According to Marksans Pharma latest financial reports the company has an operating margin of 0.17%, an increase of 15.53% to 2022. At the end of 2022 company had an operating margin of 0.15%.
Year | Operating Margin | Change |
---|---|---|
2023 | 0.17% | 15.53% |
2022 | 0.15% | -37.13% |
2021 | 0.23% | 58.75% |
2020 | 0.15% | - |